Biocon Limited has informed the Exchange about press release dated 01-Apr-2022 titled 'Biocon Biologics��� Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin for IV Infusion'.
Biocon Limited has informed the Exchange about press release dated 01-Apr-2022 titled 'Biocon Biologics��� Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin for IV Infusion'.